Skip to main contentSkip to navigation
Sirius Investors

QNNTF Stock: Quantum Genomics S.A. Stock Price, Analysis & Insights

Get live QNNTF stock price $0.10, comprehensive Quantum Genomics S.A. stock analysis, charts, news, and expert forecast. Real-time QNNTF stock data and investment insights.

0.10
0.00%Today
QNNTFQuantum Genomics S.A. • Other OTC • Healthcare
Market Cap
6.96M
Volume
4.00K
52W High
0.10
52W Low
0.10

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Quantum Genomics S.A., a biopharmaceutical enterprise headquartered in Paris, France, was established in 2005. The company specializes in advancing therapeutic solutions for cardiovascular ailments. Its drug development efforts are anchored in the br...

Company Information

CEO
Mathieu Bigois
Sector
Healthcare
Industry
Biotechnology
Employees
3

Contact Information

Address
33 rue Marbeuf
Country
FR

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.16) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Quantum Genomics S.A. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Quantum Genomics S.A.
  • Investors should consider how Quantum Genomics S.A. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

6.96M

P/E Ratio (TTM)

-0.11

Beta

0.16

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.